Hazlett, Burt & Watson, Inc. United Therapeutics Corp Transaction History
Hazlett, Burt & Watson, Inc.
- $226 Million
- Q4 2024
A detailed history of Hazlett, Burt & Watson, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Hazlett, Burt & Watson, Inc. holds 200 shares of UTHR stock, worth $62,598. This represents 0.03% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$62,598
Previous $72,000
1.39%
% of portfolio
0.03%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding UTHR
# of Institutions
725Shares Held
61MCall Options Held
123KPut Options Held
104K-
Wealthfront Advisers LLC18.3MShares$5.73 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$1.71 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.39 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$864 Million14.19% of portfolio
-
Wellington Management Group LLP Boston, MA2.46MShares$771 Million0.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...